Drug Approval | June 13, 2025
USFDA inspection at the API manufacturing plant located in Mekaguda, Hyderabad
The company received 1 (One) observation in the Form-483
The company received 1 (One) observation in the Form-483
Dilip Shanghvi to continue as the Executive Chairman of the Board
Zydus receives EIR for the API manufacturing facility at Ankleshwar
This strategic expansion marks a significant step in the company's global growth strategy
25 women students to receive internship, training, and mentorship in Life Sciences segment
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
Oxcarbazepine ER Tablets (RLD Oxtellar XR) had estimated annual sales of US$ 206 million in the US (IQVIA MAT April 2025)
46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an aggressive cancer type with limited survival and few treatment options
Subscribe To Our Newsletter & Stay Updated
